---
title: "ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300725713.md"
description: "ADARx Pharmaceuticals has recently completed the full exercise of the underwriters’ option to purchase additional shares that were initially granted in its initial public offering. This closing resulted in the purchase of an additional X shares of the company's common stock. The underwriters opted to purchase these additional shares following the success of the initial public offering."
datetime: "2026-10-01T20:17:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300725713.md)
  - [en](https://longbridge.com/en/news/300725713.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300725713.md)
generator: "portal-rs"
---

# ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering

ADARx Pharmaceuticals has recently completed the full exercise of the underwriters’ option to purchase additional shares that were initially granted in its initial public offering. This closing resulted in the purchase of an additional X shares of the company's common stock. The underwriters opted to purchase these additional shares following the success of the initial public offering.

### Related Stocks

- [ADRX.US](https://longbridge.com/en/quote/ADRX.US.md)

## Related News & Research

- [Insiders Make Bold Move as ADARx Directors Go on a Multi-Million Dollar Buying Spree](https://longbridge.com/en/news/300638144.md)
- [Adarx director Erez Chimovits acquires 61,516 shares worth $1,045,772](https://longbridge.com/en/news/300661934.md)
- [OrbiMed Advisors Discloses Investment at ADARx Pharmaceuticals with 14.0% Stake](https://longbridge.com/en/news/300830619.md)
- [HBM Healthcare Investments invests USD 15.3 million in ADARx IPO, lifts stake to 1.2%](https://longbridge.com/en/news/300253256.md)
- [Hepion Pharma director Danina Fisher acquires $10,000 in common shares](https://longbridge.com/en/news/300825627.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**